Hayashi Hiromitsu, Beppu Toru, Masuda Toshiro, Okabe Hirohisa, Imai Katsunori, Hashimoto Daisuke, Ikuta Yoshiaki, Chikamoto Akira, Watanabe Masayuki, Baba Hideo
Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan.
J Hepatobiliary Pancreat Sci. 2014 Jan;21(1):51-7. doi: 10.1002/jhbp.1. Epub 2013 Jun 20.
Partial splenic embolization (PSE) for cirrhotic patients has been reported not only to achieve an improvement in thrombocytopenia and portal hypertension, but also to induce PSE-associated fringe benefit such as individual liver functional improvement. The purpose of this study was to clarify the predictive marker of liver functional improvement due from PSE in cirrhotic patients.
From April 1999 to January 2009, 83 cirrhotic patients with hypersplenism-induced thrombocytopenia (platelet count <10 × 10(4)/μl) underwent PSE. Of them, 71 patients with follow-up for more than one year after PSE were retrospectively investigated.
In liver tissues after PSE, proliferating cell nuclear antigen (PCNA)-positive hepatocytes were remarkably increased, speculating that PSE induced liver regenerative response. Indeed, serum albumin and cholinesterase levels increased to 104 ± 14% and 130 ± 65% each of the pretreatment level at one year after PSE. In a multiple linear regression analysis, preoperative splenic volume was extracted as the predictive factor for the improvement in cholinesterase level after PSE. Cirrhotic patients with preoperative splenic volume >600 ml obtained significantly higher serum albumin and cholinesterase levels at one year after PSE compared to those with less than 600 ml (P-values were 0.029 in both).
A large preoperative splenic volume was the useful predictive marker for an effective PSE-induced liver functional improvement.
据报道,对肝硬化患者进行部分脾栓塞术(PSE)不仅可改善血小板减少症和门静脉高压,还能带来如个体肝功能改善等PSE相关的额外益处。本研究的目的是阐明肝硬化患者因PSE导致肝功能改善的预测指标。
1999年4月至2009年1月,83例因脾功能亢进导致血小板减少(血小板计数<10×10⁴/μl)的肝硬化患者接受了PSE。其中,对71例PSE术后随访超过一年的患者进行了回顾性研究。
PSE术后肝脏组织中,增殖细胞核抗原(PCNA)阳性肝细胞显著增加,推测PSE诱导了肝脏再生反应。事实上,PSE术后一年血清白蛋白和胆碱酯酶水平分别升至术前水平的104±14%和130±65%。在多元线性回归分析中,术前脾体积被提取为PSE术后胆碱酯酶水平改善的预测因素。术前脾体积>600 ml的肝硬化患者在PSE术后一年的血清白蛋白和胆碱酯酶水平显著高于脾体积小于600 ml的患者(两者P值均为0.029)。
术前脾体积较大是PSE有效诱导肝功能改善的有用预测指标。